蓝帆医疗
(002382)
| 流通市值：52.28亿 | | | 总市值：52.67亿 |
| 流通股本：10.00亿 | | | 总股本：10.07亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,584,375,145.17 | 2,261,941,112.09 | 1,094,194,474.12 | 4,900,477,569.52 |
| 营业收入 | 3,584,375,145.17 | 2,261,941,112.09 | 1,094,194,474.12 | 4,900,477,569.52 |
| 二、营业总成本 | 4,017,539,977.89 | 2,580,671,754.13 | 1,254,659,083.12 | 5,524,116,277.65 |
| 营业成本 | 3,108,642,499.61 | 1,989,732,929.95 | 954,057,593.95 | 4,398,973,474.52 |
| 税金及附加 | 26,455,764.17 | 17,818,394.34 | 9,522,201.07 | 36,917,960.26 |
| 销售费用 | 318,297,639.65 | 205,888,440.42 | 90,910,850.58 | 370,591,527.83 |
| 管理费用 | 229,616,760.43 | 155,315,341.18 | 69,798,416.04 | 331,272,797.66 |
| 研发费用 | 227,027,452.75 | 137,179,421.83 | 71,330,456.77 | 352,487,637.72 |
| 财务费用 | 107,499,861.28 | 74,737,226.41 | 59,039,564.71 | 33,872,879.66 |
| 其中:利息费用 | 133,472,653.54 | 91,398,674.55 | 38,507,416.04 | 129,476,886.3 |
| 其中:利息收入 | 17,128,802.95 | 19,887,440.7 | 6,637,607.84 | 36,732,071.57 |
| 加:公允价值变动收益 | 71,166,976.29 | 71,120,611.76 | 71,988,379.25 | -6,741,685.86 |
| 加:投资收益 | 21,946,542.69 | 16,230,654.06 | 6,827,686.29 | 257,711,883.37 |
| 资产处置收益 | -224,652.99 | -176,810.94 | -286,571.18 | 72,349.83 |
| 资产减值损失(新) | -56,231,684.98 | -39,831,028.28 | -31,597,662.76 | -82,338,009.24 |
| 信用减值损失(新) | -18,853,005.64 | -9,822,639.48 | -346,584.99 | -10,245,259.98 |
| 其他收益 | 25,843,396.85 | 22,412,114.79 | 16,151,114.67 | 63,100,527.76 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | -389,517,260.5 | -258,797,740.13 | -97,728,247.72 | -402,078,902.25 |
| 加:营业外收入 | 7,039,392.49 | 9,034,843.78 | 5,197,284.31 | 5,883,640.35 |
| 减:营业外支出 | 1,569,924.56 | 778,124.62 | -1,534,499.88 | 9,664,866.94 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -384,047,792.57 | -250,541,020.97 | -90,996,463.53 | -405,860,128.84 |
| 减:所得税费用 | -28,410,007.81 | -13,931,144.01 | -13,696,643.42 | -33,543,819.7 |
| 六、净利润 | -355,637,784.76 | -236,609,876.96 | -77,299,820.11 | -372,316,309.14 |
| 持续经营净利润 | -355,637,784.76 | -236,609,876.96 | -77,299,820.11 | -372,316,309.14 |
| 归属于母公司股东的净利润 | -355,637,784.76 | -236,609,876.96 | -77,299,820.11 | -372,316,293.48 |
| 少数股东损益 | - | - | - | -15.66 |
| (一)基本每股收益 | -0.35 | -0.23 | -0.08 | -0.37 |
| (二)稀释每股收益 | -0.35 | -0.23 | -0.08 | -0.37 |
| 八、其他综合收益 | 122,126,716.09 | 124,831,783.64 | -61,212,648.44 | 344,092,778.58 |
| 归属于母公司股东的其他综合收益 | 122,126,716.09 | 124,831,783.64 | -61,212,648.44 | 344,092,778.58 |
| 九、综合收益总额 | -233,511,068.67 | -111,778,093.32 | -138,512,468.55 | -28,223,530.56 |
| 归属于母公司股东的综合收益总额 | -233,511,068.67 | -111,778,093.32 | -138,512,468.55 | -28,223,514.9 |
| 归属于少数股东的综合收益总额 | - | - | - | -15.66 |
| 公告日期 | 2023-10-31 | 2023-08-31 | 2023-04-29 | 2023-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |